Impact of Identification and Treatment of Depression in Heart Transplant Patients

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Grade</td><td align="left">Description</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">0R</td><td align="left">No evidence of acute cellular rejection</td></tr><tr><td align="left">1R</td><td align="left">Mononuclear cells infiltration without or with only one focus of myocyte damage</td></tr><tr><td align="left">2R</td><td align="left">An infiltrate plus the presence of multifocal myocyte damage</td></tr><tr><td align="left">3R</td><td align="left">An infiltrate with diffuse myocyte  damage and/or associated edema, hemorrhage, or vasculitis</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

International Heart and Lung Transplant Society acute rejection criteria.

Cardiovascular Psychiatry and Neurology

tab3

Table 3

Table 3: Impact of Identification and Treatment of Depression in Heart Transplant Patients 